x

Posted 01 September, 2022

MediXall Group, Inc. appointed new CEO

CEO Change detected for ticker OTC:MDXL in a 8-K filed on 01 September, 2022.


  On August 30, 2022, MediXall Group, Inc. (the "Company") announced the departure of Mr. Noel Guillama as Chairman and CEO of MediXall.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of MediXall Group, Inc.
Business/Consumer Services • Diversified Business Services
MediXall Group, Inc. is a technology company, which engages in the development of a healthcare marketplace platform. It operates through the Medixall.com and Medixall Finance Group divisions. The Medixall.com division focuses on the healthcare ecosystem. The Medixall Finance Group division is involved in the strategic alliance of financing specialists that create funding opportunities for healthcare practice growth and expansion, as well as financing for medical procedures and accounts receivable lines of credit. The company was founded on December 21, 1998 and is headquartered in Fort Lauderdale, FL.
Market Cap
$0.13K
View Company Details
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On August 30, 2022, MediXall Group, Inc. (the "Company") announced the departure of Mr. Noel Guillama as Chairman and CEO of MediXall. Mr. Guillama's departure was not a result of a disagreement relating to the registrant's operations, policies or practices. Mr. Guillama had served as Chairman and CEO since June 2022.


On August 30, 2022, upon Noel Guillama's departure, the Board of Directors ("Board") announced the appointment of Timothy Hart as Chairman of the Board of Directors of MediXall Group, Inc. Mr. Hart has served as our Chief Financial Officer and member of our board of directors since 2012. Mr. Hart has over 30 years of accounting and finance experience. Since 2013, Mr. Hart has been the CFO and a director of Monkey Rock Group, Inc. (OTC Markets: MKRO), and since 2014, Mr. Hart has been the CFO and a director of Vanell, Corp. (OTC Markets: VANL). Mr. Hart has held the position of CFO of TBG since 2012 and has served as a director since 2013. In addition, Mr. Hart has held the position of CFO of TBG Investment Partners, LLLP since 2013. He has also served as CFO of A1 Group, Inc. since 2015. Mr. Hart has been providing accounting and consulting services through R3 Accounting LLC, a private accounting firm he formed in 2008. He consulted extensively with RailAmerica, Inc., a NYSE-listed holding company for short line and regional railroads in the U.S. which was acquired by Fortress Investment Group in 2007, during its initial public offering, and assisted the company with governmental compliance. Mr. Hart's firm also provided consulting, strategic tax planning and compliance, and acquisition audits for Patriot Rail Corp., a Boca Raton, Florida based company which is an operator of short line and regional railroads in the U.S. Mr. Hart served as Chief Financial Officer of Alternative Americas Fuels, Inc. (OTCBB: AFAI) 2011 until 2012. Mr. Hart holds a B.A. in Accountancy, Economics and Business Administration from Thomas More University, and has been a certified public accountant since 1984. Mr. Hart devotes approximately 66% of his time to our business and operations.


On August 30, 2022, the Company appointed Travis Jackson, Chief Executive Officer of MediXall Group, Inc., Mr. Jackson is currently a member of the Board of Directors of the Company. Mr. Jackson will work under his existing employment agreement which call for $205,000 annual base salary and 1,000,000 shares of MediXall Group, Inc. common stock. Mr. Jackson was most recently the VP of Strategy & Business Development for Beacon Health Options from (June 2018-August 2021), one of the largest behavioral health organizations in the country. Beacon serves more than 40 million individuals across all 50 states, including nearly 3 million individuals under comprehensive risk-based behavioral programs. During his tenure as VP, he led sales, strategy and business development for the company in the West and Midwest US, with his sales efforts directed towards commercial health insurance plans, state and county Medicaid plans and large Third Party Administrators. While at Beacon, the Company was acquired by Anthem in 2020 and currently resides as a wholly owned subsidiary in Anthem's Diversified Business Group. Prior to Beacon, Mr. Jackson was Executive VP of Sales for Linkwell Health from (August 2017- June 2018), where he was responsible for national sales and marketing activities for the company, with these efforts directed towards health insurance plans, hospital systems and health services companies. Mr. Jackson also has had success in his career building new businesses. He was a founder of both Ascendant Behavioral Health and Highland Springs Specialty Clinics, a series of outpatient behavioral health clinics. Mr. Jackson was responsible for clinic set up including locations, billing, hiring and staffing, IT set up and clinic processes. Prior to that, Mr. Jackson was Founding Partner & Executive Vice President of Sales of My ePHIT from (2000-2006), where he created a multimillion-dollar company from an initial idea, through fundraising, production, active sales and service and renewal phases. During his time, he participated in the Executive Leadership Team of the company creating, reviewing and approving all strategy and operations, and was one of the key decision makers in the sale of the company. At time of sale, My ePHIT had achieved over 23 million paid members.